Watershed Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$276K Buy
586
+7
+1% +$3.24K 0.32% 92
2023
Q3
$252K Buy
579
+21
+4% +$9.53K 0.3% 93
2023
Q2
$248K Sell
558
-11
-2% -$5.07K 0.31% 82
2023
Q1
$262K Buy
569
+52
+10% +$24.7K 0.32% 75
2022
Q4
$265K Sell
517
-21
-4% -$10.7K 0.34% 50
2022
Q3
$244K Hold
538
0.32% 26
2022
Q2
$260K Sell
538
-67
-11% -$33.1K 0.32% 33
2022
Q1
$297K Hold
605
0.3% 32
2021
Q4
$280K Buy
+605
New +$255K 0.25% 72

Other funds holding ELV

Watershed Asset Management's ELV Position: Q4 2023 in Review

Watershed Asset Management increased its Elevance Health (ELV) stake by 1.2% in Q4 2023, buying an estimated $3.24K and bringing the position to 586 shares worth $276K. The position accounts for 0.32% of the portfolio, ranked #92.

Watershed Asset Management first reported a position in ELV in Q4 2021 and has held it in 9 quarters since. The position peaked at $297K in Q1 2022. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Watershed Asset Management held 586 shares of Elevance Health worth $276K as of Q4 2023.
  • Watershed Asset Management bought 7 Elevance Health shares in Q4 2023, an estimated $3.24K.
  • Elevance Health made up 0.32% of Watershed Asset Management's portfolio in Q4 2023, its #92 holding.
  • Watershed Asset Management first reported a position in Elevance Health in Q4 2021 and has held it in 9 quarters since.
  • Watershed Asset Management's Elevance Health position peaked at $297K in Q1 2022.
  • 1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Watershed Asset Management's 13F filing for Q4 2023, filed 2 Feb 2024.